Both Seaport Therapeutics and Hemab Therapeutics are hoping to bring in around $180 million each from their public listings ...

With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British biotech’s future.

The company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm.

The healthcare- and pharma-focused investment company BB Biotech posted a loss in the first quarter. However, it was smaller ...

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke ...

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more ...

Columbus-area institutions are updating their degree programs to meet employers’ changing needs—particularly in the ...

The findings position Intellia to bring to market the first “in vivo” gene editing medicine, though the therapy’s commercial ...

Alabama A&M University students made a strong showing at a statewide biotechnology symposium, bringing home top honors at the ...

Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...

The "Writing Inspection-Ready SOPs: Best Practice for Compliance and Control (July 14, 2026)" has been added to ResearchAndMarkets.com's offering. In the pharmaceutical and biotech sectors, Standard ...

Lucknow University raises PG application fees for 2026-27: +50% for general courses, +25% for professional programmes; some course fees up 20%-85%.